Prevention of experimentally induced irritant contact dermatitis by extracts of Isatis tinctoria compared to pure tryptanthrin and its impact on UVB-induced erythema

Planta Medica

Volumn 70, Issue 5, 2004, Pages 385-390

  Heinemann, Christian ^a   Schliemann Willers, Sibylle ^a   Oberthür, Christine ^a   Hamburger, Matthias ^a   Elsner, Peter ^a  

^a FRIEDRICH SCHILLER UNIVERSITY JENA   (Germany)

Author keywords

Anti inflammatory agents; Brassicaceae; Irritant contact dermatitis; Isatis tinctoria; Sodium lauryl sulphate; Tryptanthrin; UVB erythema; Woad

Indexed keywords

ALKALOID; DODECYL SULFATE SODIUM; ISATIS TINCTORIA EXTRACT; PLANT EXTRACT; TRYPTANTHRIN; UNCLASSIFIED DRUG;

ADULT; ANTIINFLAMMATORY ACTIVITY; ARTICLE; BACK; BIOENGINEERING; CHROMAMETRY; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG EFFICACY; ERYTHEMA; EVAPORIMETRY; FEMALE; HUMAN; IRRADIATION; IRRITANT DERMATITIS; ISATIS; ISATIS TINCTORIA; LIPOPHILICITY; MALE; METHODOLOGY; RANDOMIZED CONTROLLED TRIAL; SINGLE BLIND PROCEDURE; STATISTICAL SIGNIFICANCE; TECHNIQUE; ULTRAVIOLET B RADIATION; WATER LOSS;

ADOLESCENT; ADULT; ANTI-INFLAMMATORY AGENTS; DERMATITIS, ALLERGIC CONTACT; DRUGS, CHINESE HERBAL; ERYTHEMA; FEMALE; HUMANS; ISATIS; MALE; PHYTOTHERAPY; PLANT EXTRACTS; PLANT LEAVES; QUINAZOLINES; SINGLE-BLIND METHOD; SODIUM DODECYL SULFATE; TREATMENT OUTCOME; ULTRAVIOLET RAYS;

BRASSICACEAE; ISATIS; ISATIS TINCTORIA;

EID: 2642575863     PISSN: 00320943     EISSN: None     Source Type: Journal    
DOI: 10.1055/s-2004-818963     Document Type: Article

References (21)

1. Thiers BH. Topical steroid therapy of atopic skin diseases. Allergy Proc 1989; 10: 413-6
2. Wichtl M. Teedrogen und Phytopharmaka. 4th Edition. Stuttgart: Wissenschaftliche Verlagsgessellschaft, 2002
3. Hurry JB. The woad plant and its dye. London: Oxford University Press, 1930
4. Tang W, Eisenbrand G. Chinese drugs of Plant Origin. Berlin: Springer-Verlag, 1992
5. Hamburger M. Isatis tinctoria - from the rediscovery of an ancient medicinal plant towards a novel anti-inflammatory phytopharmaceutical. Phytochem Rev 2002; 1: 333-44
6. Danz H, Stoyanova S, Wippich P, Brattström A, Hamburger M. Identification and isolation of the cyclooxygenase-2 inhibitory principle in Isatis tinctoria. Planta Med 2001; 67: 411-6
7. Danz H, Stoyanova S, Thomet OAR, Simon HU, Dannhardt G, Ulbrich H et al. Inhibitory activity of tryptanthrin on cyclooxygenases-1 and -2, and 5-lipoxygenase. Planta Med 2002; 68: 875-80
8. Oberthür C, Heinemann C, Elsner P, Benfeldt E, Hamburger M. A comparative study on the skin penetration of pure tryptanthrin and tryptanthrin in Isatis tinctoria extract by subcutaneous microdialysis coupled with isotope dilution ESI-LC-MS. Planta Med 2003; 69: 385-9
9. Danz H, Baumann D, Hamburger M. Quantitative determination of the dual COX-2/5-LOX inhibitor tryptanthrin in Isatis tinctoria by ESI-L-MS. Planta Med 2002; 68: 152-7
10. Friedländer P, Roschdestwensky N. Über ein Oxidationsprodukt des Indigoblaus. Ber dtsch chem Ges 1915; 48: 1841-7
11. Wigger-Alberti W, Krebs A, Elsner P. Experimental irritant contact dermatitis due to cumulative epicutaneous exposure to sodium lauryl sulphate and toluene: single and concurrent application. Br J Dermatol 2000; 143: 551-6
12. Bangha E, Elsner P, Kistler GS. Suppression of UV-induced erythema by topical treatment with melatonin (N-acetyl-5-methoxytryptamine). Influence of the application time point. Dermatology 1997; 195: 248-52
13. Frosch PJ, Kligman AM. The soap chamber test. A new method for assessing the irritancy of soaps. J Am Acad Dermatol 1979; 1: 35-41
14. Pinnagoda J, Tupker RA, Agner T, Serup J. Guidelines for transepidermal water loss (TEWL) measurement. A report from the Standardization Group of the European Society of Contact Dermatitis. Contact Dermatitis 1990; 22: 164-78
15. Elsner P. Chromametry. In: Handbooks of Skinbioengeneering. Cutaneous blood flow and Erythema. (Berardesca E., Elsner P., Maibach H., eds). Boca Raton: CRC Press, 1994: pp 247-52
16. Van der Valk PG, Maibach HI. Do topical corticosteroids modulate skin irritation in human beings? Assessment by transepidermal water loss and visual scoring. J Am Acad Dermatol 1989; 21 (3Pt1): 519-22
17. Eder M, Mehnert W. Bedeutung pflanzlicher Begleitstoffe in Extrak7-ten. Pharmazie 1998; 53: 285-93
18. Crofford LJ. COX-1 and COX-2 tissue expression: implications and predictions. J Rheumatol 1997; 24 (Suppl 21): 15-9
19. Muller-Decker K, Heinzelmann T, Furstenberger G, Kecskes A, Lehmann WD, Marks F. Arachidonic acid metabolism in primary irritant dermatitis produced by patch testing of human skin with surfactants. Toxicol Appl Pharmacol 1998; 153: 59-67
20. Wilgus TA, Ross MS, Parrett ML, Oberyszyn TM. Topical application of a selective cyclooxygenase inhibitor suppresses UVB mediated cutaneous inflammation. Prostaglandins Other Lipid Mediat 2000; 62: 367-84
21. Camp RD, Greaves MW, Hensby CN, Plummer NA, Warin AP. Irradiation of human skin by short wavelength ultraviolet radiation (100-290 nm) (u.v.C): increased concentrations of arachidonic acid and prostaglandins E2 and F2-α. Br J Clin Pharmacol 1978; 6: 145-8